Search Results - "Ahmed, Tuli"

Lack of effect of aprepitant on the pharmacokinetics of docetaxel in cancer patients by NYGREN, Peter, HANDE, Kenneth, GOTTESDIENER, Keith M, COCQUYT, Veronique, VAN BELLE, Simon, PETTY, Kevin J, FEDGCHIN, Margaret, VAN DYCK, Kristien, MAJUMDAR, Anup, PANEBIANCO, Debbie, DE SMET, Marina, AHMED, Tuli, MURPHY, M. Gail

“…Aprepitant is a selective neurokinin-1 receptor antagonist that is effective for the prevention of nausea and vomiting caused by highly emetogenic…”
Get full text

Efficacy and safety of sitagliptin monotherapy in Japanese patients with type 2 diabetes by Nonaka, Kenji, Kakikawa, Taro, Sato, Asako, Okuyama, Kotoba, Fujimoto, Go, Kato, Naoki, Suzuki, Hideyo, Hirayama, Yukio, Ahmed, Tuli, Davies, Michael J, Stein, Peter P

“…Abstract Efficacy and tolerability of sitagliptin, a dipeptidyl peptidase-4 inhibitor, were assessed in Japanese patients with type 2 diabetes. In a…”
Get full text

A double-blind, dose-response study of losartan in hypertensive children by Shahinfar, Shahnaz, Cano, Francisco, Soffer, Beth A., Ahmed, Tuli, Santoro, Emanuela P., Zhang, Zhongxin, Gleim, Gilbert, Miller, Kenneth, Vogt, Beth, Blumer, Jeffrey, Briazgounov, Igor

“…The aim of this study was to determine the dose-response relationship for losartan, 2.5 to 100 mg, and to assess the safety and tolerability of losartan in…”
Get full text

Pharmacokinetics and Safety of Montelukast Oral Granules in Children 1 to 3 Months of Age With Bronchiolitis by Kearns, Gregory L., Lu, Susan, Maganti, Lata, Li, Xiujiang (Susie), Migoya, Elizabeth, Ahmed, Tuli, Knorr, Barbara, Reiss, Theodore F.

“…The single‐dose pharmacokinetics of montelukast 4‐mg oral granules and tolerability of daily administration of 2 different doses of montelukast (4 mg and 8 mg…”
Get full text

Effect of Aprepitant on the Pharmacokinetics of Intravenous Midazolam by Majumdar, Anup K., Yan, Kerri X., Selverian, Diana V., Barlas, Suna, Constanzer, Marvin, Dru, James, McCrea, Jacqueline B., Ahmed, Tuli, Frick, Glen S., Kraft, Walter K., Petty, Kevin J., Greenberg, Howard E.

“…Oral aprepitant 125 mg, an antiemetic and a moderate inhibitor of the metabolism of oral midazolam, was assessed for interaction with intravenous midazolam in…”
Get full text

Lack of Effect of Aprepitant on Hydrodolasetron Pharmacokinetics in CYP2D6 Extensive and Poor Metabolizers by Li, Susie Xiujiang, Pequignot, Edward, Panebianco, Deborah, Lupinacci, Paul, Majumdar, Anup, Rosen, Laura, Ahmed, Tuli, Royalty, Jane E., Rushmore, Thomas H., Murphy, M. Gail, Petty, Kevin J.

“…To prevent chemotherapy‐induced nausea and vomiting, aprepitant is given with a corticosteroid and a 5‐hydroxytryptamine type 3 antagonist, such as dolasetron…”
Get full text

A Comparison of Cardiovascular Biomarkers in Patients Treated for Three Months with Etoricoxib, Celecoxib, Ibuprofen, and Placebo by Cannon, Christopher P., Chen, Cong, Curtis, Sean P., Viscusi, John, Ahmed, Tuli, DiBattiste, Peter M.

“…ABSTRACT Objectives.  Selective cyclooxygenase (COX)‐2 inhibitors are effective analgesic and anti‐inflammatory agents with improved gastrointestinal safety…”
Get full text

A double-blind, dose-response study of losartan in hypertensive children by SHAHINFAR, Shahnaz, CANO, Francisco, BRIAZGOUNOV, Igor, SOFFER, Beth A, AHMED, Tuli, SANTORO, Emanuela P, ZHONGXIN ZHANG, GLEIM, Gilbert, MILLER, Kenneth, VOGT, Beth, BLUMER, Jeffrey

Get full text